Olatunji Alese MD
- Department of Hematology and Medical Oncology
Associate Professor
- (404) 778-6639
- olatunji.alese@emory.edu
Overview
A board certified medical oncologist, Dr. Alese specializes in the treatment of gastrointestinal cancers, particularly colorectal cancer. He joined the clinical staff at Winship Cancer Institute as a practicing physician in July 2015.
Dr. Alese serves as director of gastrointestinal oncology at Winship Cancer Institute of Emory University.
Dr. Alese is a member of the Discovery and Developmental Therapeutics research program at Winship Cancer Institute. He previously served on the Advisory Group of ASCO International Affairs Committee, and he is a member of several professional organizations.
Dr. Alese received his MD from University of Ibadan, Nigeria in 2000. His postgraduate medical education included residency training at University College Hospital in Nigeria and New York Medical College - Metropolitan Hospital Center. He completed his fellowship in hematology/oncology at Winship Cancer Institute of Emory University.
Dr. Alese's research focuses on colorectal cancer and health disparities.
Dr. Alese has several awards including the American Society of Clinical Oncology (ASCO) International Development and Education Award (IDEA), and ECOG Foundation/Paul Carbone, MD Fellowship award. A previous German Academic Exchange Service (DAAD) scholar, his additional distinctions and awards include University of Ibadan Skilled Hands Award, UICC International Cancer Technology Transfer Fellowship, European Society for Medical Oncology (ESMO) TRU Visit Grant, and 2014 ASCO Merit award.
Academic Appointment
- Associate Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine
Education
Degrees
- MD from University of Ibadan, Ibadan
Research
Publications
-
Utilizing Patient Input in Rectal Cancer Trial Design.
J Natl Cancer Inst
03/19/2025 Authors: Alvarez J; Zambare W; George M; Garcia R; Gallagher P; Kitchens C; Bercz A; Kim MJ; Romesser PB; Cercek A -
Mechanism of enhancing chemotherapy efficacy in pancreatic ductal adenocarcinoma with paricalcitol and hydroxychloroquine.
Cell Rep Med Volume: 6 Page(s): 101881
01/21/2025 Authors: Nagaraju GP; Saddala MS; Foote JB; Khaliq AM; Masood A; Golivi Y; Bandi DSR; Sarvesh S; Reddy SP; Switchenko J -
Perceptions and Needs for a Technology-Based Dyadic Intervention on Symptom Management Among Patients With Colorectal Cancer and Their Caregivers: A Qualitative Study.
Cancer Nurs
11/29/2024 Authors: Epari A; Kim K; Xiao C; Porter LS; Alese OB; Northouse L; Liu D; Graetz I; Lin Y -
Relacorilant plus nab-paclitaxel for the treatment of metastatic pancreatic ductal adenocarcinoma: results from the open-label RELIANT study.
Oncologist Volume: 29 Page(s): 957 - 965
11/04/2024 Authors: Borazanci EH; Bahary N; Chung V; Huyck TK; Kio EA; Chiorean EG; Skeel RT; Alese OB; Cardin DB; Fountzilas C -
A pilot study of the immune microenvironment of GI neuroendocrine carcinoma.
Endocr Relat Cancer Volume: 31
10/01/2024 Authors: McDonald A; Avadhani V; Oprea-Ilies G; Zakka K; Lesinski GB; Gbolahan OB; Alese O -
Pertuzumab Plus Trastuzumab in Patients With Biliary Tract Cancer With ERBB2/3 Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study.
J Clin Oncol Volume: 42 Page(s): 3228 - 3237
09/20/2024 Authors: Cannon TL; Rothe M; Mangat PK; Garrett-Mayer E; Chiu VK; Hwang J; Vijayvergia N; Alese OB; Dib EG; Duvivier HL -
Alliance A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer.
BMC Cancer Volume: 24 Page(s): 901
07/26/2024 Authors: Alvarez JA; Shi Q; Dasari A; Garcia-Aguilar J; Sanoff H; George TJ; Hong T; Yothers G; Philip P; Nelson G -
Development of a Technology-Based Dyadic Intervention for Underserved Colorectal Cancer Patients and Caregivers.
Stud Health Technol Inform Volume: 315 Page(s): 721 - 722
07/24/2024 Authors: Lin Y; Xiao C; Porter LS; Alese OB; Higgins MK; Liu DS; Bold D; Hu X -
Transposon DNA sequences facilitate the tissue-specific gene transfer of circulating tumor DNA between human cells.
Nucleic Acids Res Volume: 52 Page(s): 7539 - 7555
07/22/2024 Authors: Cinar M; Martinez-Medina L; Puvvula PK; Arakelyan A; Vardarajan BN; Anthony N; Nagaraju GP; Park D; Feng L; Sheff F -
ALLIANCE A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer.
medRxiv
04/27/2024 Authors: Alvarez J; Shi Q; Dasari A; Garcia-Aguilar J; Sanoff H; George TJ; Hong TS; Yothers G; Philip PA; Nelson GD